11:58 : Shares of microcap biotech firm Alexza Pharmaceuticals ([[ALXA]] -14.6%) ... -
Shares of microcap biotech firm Alexza Pharmaceuticals (ALXA -14.6%) get slammed after the FDA says it needs an additional three months to complete its review of the company's new drug application for Adasuve, a schizophrenic ...
11:09 : Pharma News: Alexza Pharmaceuticals, YM BioSciences -
Alexza Pharmaceuticals (ALXA) said today the U.S. Food and Drug Administration’s psychopharmacologic advisory committee voted to recommend its schizophrenia and bipolar mania treatment Adasuve for approval.
10:05 : Alexza Pharmaceuticals Inc. (ALXA) Video Chart for Tuesday, May 31, 2011 -
ALXA has been in a solid uptrend since a large gap down last October. The stock made a nice move on Friday, capturing the attention of technical traders as the stock price moved through a near-term resistance level and could be poised to challenge ...